A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php74/ci_sessionc923f39071619fdb6005d10004d5220f0a9d8832): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/drugtodayonline/public_html/application/controllers/Medical_news.php
Line: 9
Function: __construct

File: /home/drugtodayonline/public_html/index.php
Line: 311
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php74)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/drugtodayonline/public_html/application/controllers/Medical_news.php
Line: 9
Function: __construct

File: /home/drugtodayonline/public_html/index.php
Line: 311
Function: require_once

USFDA approves ropeginterferon alfa-2b-njft for rare blood disease

Look for Drugs and Conditions

Reference pic

USFDA approves ropeginterferon alfa-2b-njft for rare blood disease

DTMT Network

The United States Foods and Drug Administration (FDA) has approved PharmaEssentia Corporation’s ropeginterferon alfa-2b-njft (Besremi) giving it an orphan drug designation for the treatment of ‘polycythemia vera’, a rare form of blood disease, that results in over-production of red blood cells.

The disease thickens the blood and patients develop the risk of clotting if untreated, an official statement released by FDA said.

Ann Farrell, director of the Division of Non-Malignant Hematology in the FDA’s Center for Drug Evaluation and Research said that “Polycythemia vera affects approximately 6,200 Americans each year.”

“This action highlights the FDA’s commitment to helping make new treatments available to patients with rare diseases,” she added.

Polycythemia vera usually is treated through management of symptoms like withdrawal of blood frequently, depending upon conditions, or using bone marrow suppressants.

Besremi is the first FDA-approved medication for polycythemia vera that patients can take regardless of their treatment history, and the first interferon therapy specifically approved for polycythemia vera, the statement added.

Patients can take injections of Besremi under the skin once every two weeks initially for one year, and if the drug is able to reduce the blood volume, its frequency can be reduced up to once every four weeks.  

However, Besremi can result in increasing the level of liver enzyme levels, low levels of white blood cells, low levels of platelets, joint pain, fatigue, itching, upper airway infection, muscle pain and flu-like illness. Side effects may also include urinary tract infection, depression and stroke-like attacks, FDA cautioned.

It can risk fetal harm and patients should be tested for pregnancy before administering Besremi, it further warned.


0 Comments
Be first to post your comments

Post your comment

Related Articles

A PHP Error was encountered

Severity: Warning

Message: mysqli::query(): (HY000/1): Can't create/write to file '/tmp/#sql_3e5_0.MYI' (Errcode: 28 - No space left on device)

Filename: mysqli/mysqli_driver.php

Line Number: 307

Backtrace:

File: /home/drugtodayonline/public_html/application/models/Site_ads_model.php
Line: 118
Function: query

File: /home/drugtodayonline/public_html/application/libraries/Common_lib.php
Line: 318
Function: get_front_ads_data

File: /home/drugtodayonline/public_html/application/views/front/news_topic.php
Line: 332
Function: common_footer_ads

File: /home/drugtodayonline/public_html/application/controllers/Medical_news.php
Line: 361
Function: view

File: /home/drugtodayonline/public_html/application/controllers/Medical_news.php
Line: 28
Function: news_topic

File: /home/drugtodayonline/public_html/index.php
Line: 311
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: Cannot modify header information - headers already sent by (output started at /home/drugtodayonline/public_html/system/core/Exceptions.php:271)

Filename: core/Common.php

Line Number: 570

Backtrace:

File: /home/drugtodayonline/public_html/application/models/Site_ads_model.php
Line: 118
Function: query

File: /home/drugtodayonline/public_html/application/libraries/Common_lib.php
Line: 318
Function: get_front_ads_data

File: /home/drugtodayonline/public_html/application/views/front/news_topic.php
Line: 332
Function: common_footer_ads

File: /home/drugtodayonline/public_html/application/controllers/Medical_news.php
Line: 361
Function: view

File: /home/drugtodayonline/public_html/application/controllers/Medical_news.php
Line: 28
Function: news_topic

File: /home/drugtodayonline/public_html/index.php
Line: 311
Function: require_once

Database Error

A Database Error Occurred

Error Number: 1

Can't create/write to file '/tmp/#sql_3e5_0.MYI' (Errcode: 28 - No space left on device)

SELECT * FROM `dt_site_ads` WHERE `status` = '1' and `loc` = 'pre_footer_4' ORDER BY RAND() LIMIT 0,1

Filename: models/Site_ads_model.php

Line Number: 118